Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer
- PMID: 24354113
Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer
Abstract
This multicenter, randomized, crossover, open-label study (ClinicalTrials.gov identifier: NCT01161563) assessed patients'and clinicians'perceptions of injection site tolerability and adverse events following the intramuscular injection of triptorelin pamoate or subcutaneous injection of leuprolide acetate in 107 male, patients with advanced prostate cancer.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical